Researchers develop novel test that screens for SARS-CoV-2 variants of concern
A team of scientists from the United States has recently developed a single-tube duplex molecular assay for rapid detection of […]
With over 127.8 million cases of coronavirus disease 2019 (COVID-19) already documented, and many more millions that have undoubtedly gone […] Acriflavine is traditionally employed as a topical antiseptic, though has more recently been implicated as an antiviral agent at low […] The coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to spread globally, with […] The heterogeneous coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in Wuhan, […] Nanomedicine is a very powerful tool with the potential to mitigate the burden of disease by providing nanoparticle-based carriers and […] COVID-19 (coronavirus disease 2019) is caused by a new positive-strand RNA coronavirus, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), […] A team of scientists in Israel recently evaluated the efficacy of an mRNA-based coronavirus disease 2019 (COVID-19) vaccine, BNT162b2 (also […] When researchers analyzed the responses of the COVID-19 Symptom Survey in the United States, they found an increased risk of […] Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of the coronavirus disease 2019 (COVID-19) pandemic. To date, […]Coronavirus Disease COVID-19
Proper choice of control group nullifies most observed genetic markers for severe COVID-19, study suggests
Researchers examine acriflavine's antiviral potential against SARS-CoV-2
Scientists explore structure of SARS-CoV-2 receptor-binding domain with G485R mutation
Living with a COVID-19 case brings worse symptoms and stronger antibody response
The role of nanotechnology in the fight against COVID-19
Self-assembling nanoparticles an effective vaccine candidate for SARS-CoV-2
Data from Israel’s vaccination program suggests Pizer-BioNTech COVID-19 vaccine induces strong host antibody response
COVID risk to households and teachers from in person schooling
Corticosteroid receptor inhibitor shows anti-SARS-CoV-2 activity in vivo